Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

35.29
+0.33190.95%
Volume:227
Turnover:8K
Market Cap:16.58M
PE:- -
High:35.30
Open:35.30
Low:35.29
Close:34.96
52wk High:37.90
52wk Low:28.87
Shares:469.95K
Float Shares:469.95K
Volume Ratio:0.09
T/O Rate:0.05%
Dividend:0.41
Dividend Rate:1.16%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novartis's Multiple Sclerosis Trial Results Match Best Hopes

Dow Jones
·
Sep 01

US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy

Stock News
·
Sep 01

Novartis up Nearly 6%, on Pace for Largest Percent Increase Since March 2023

Dow Jones
·
Sep 01

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

MT Newswires Live
·
Sep 01

【US Pre-Market】US Futures and Chip Stocks Fall as Global Bond Sell-Off Deepens; Gold Drops Below $4,400, Brent Crude Tops $92

TradingKey
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Tellgen Corporation Secures Six New Medical Device Approvals

Stock News
·
Sep 01

Why Novartis Stock is Heading for Its Best Day Since 2023 After 3 Patient Deaths

Dow Jones
·
Sep 01

Medical Sector Hitting an Earnings Inflection Point? 512170 Ends Green Amid AI4S Boost for HK CXO Stocks

Deep News
·
Sep 01

NetraMark Appoints Abivax Regulatory Chief Keith Fournier to Board

Reuters
·
Sep 01

Satellos to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 01

Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials

Dow Jones
·
Sep 01

Novartis announces results from Phase III Remodel-1/-2 trials of remibrutinib

TIPRANKS
·
Sep 01

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

TIPRANKS
·
Sep 01

Novartis Says Remibrutinib Significantly Reduces Relapse Rates in Phase 3 Multiple Sclerosis Trials

MT Newswires Live
·
Sep 01